Home
>
National Drug Code (NDC)
>
HyperTET
HyperTET - 13533-634-02 - (Tetanus Immune Globulin (Human))
Drug Information of HyperTET
| Product NDC: | 13533-634 |
| Proprietary Name: | HyperTET |
| Non Proprietary Name: | Tetanus Immune Globulin (Human) |
| Active Ingredient(s): | 250 [iU]/mL & nbsp; Tetanus Immune Globulin (Human) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HyperTET
| Product NDC: | 13533-634 |
| Labeler Name: | Grifols Therapeutics Inc. |
| Product Type: | PLASMA DERIVATIVE |
| FDA Application Number: | BLA101142 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19960814 |
Package Information of HyperTET
| Package NDC: | 13533-634-02 |
| Package Description: | 1 SYRINGE, GLASS in 1 BOX (13533-634-02) > 1 mL in 1 SYRINGE, GLASS (13533-634-20) |
NDC Information of HyperTET
| NDC Code | 13533-634-02 |
| Proprietary Name | HyperTET |
| Package Description | 1 SYRINGE, GLASS in 1 BOX (13533-634-02) > 1 mL in 1 SYRINGE, GLASS (13533-634-20) |
| Product NDC | 13533-634 |
| Product Type Name | PLASMA DERIVATIVE |
| Non Proprietary Name | Tetanus Immune Globulin (Human) |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19960814 |
| Marketing Category Name | BLA |
| Labeler Name | Grifols Therapeutics Inc. |
| Substance Name | HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN |
| Strength Number | 250 |
| Strength Unit | [iU]/mL |
| Pharmaceutical Classes |
